{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T02:30:13Z","timestamp":1767839413176,"version":"3.49.0"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2007,7,4]],"date-time":"2007-07-04T00:00:00Z","timestamp":1183507200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0000584","type":"journal-article","created":{"date-parts":[[2007,7,3]],"date-time":"2007-07-03T18:45:22Z","timestamp":1183488322000},"page":"e584","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["A Novel Unsupervised Method to Identify Genes Important in the Anti-viral Response: Application to Interferon\/Ribavirin in Hepatitis C Patients"],"prefix":"10.1371","volume":"2","author":[{"given":"Leonid I.","family":"Brodsky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdus S.","family":"Wahed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John E.","family":"Tavis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuma","family":"Tsukahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milton W.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2007,7,4]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1111\/j.1572-0241.2000.03433.x","article-title":"A multicenter, randomized trial of daily high-dose interferon-alfa 2b for the treatment of chronic hepatitis c: pretreatment stratification by viral burden and genotype,","volume":"95","author":"MW Fried","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection,","volume":"347","author":"MW Fried","year":"2002","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","article-title":"Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial,","volume":"358","author":"MP Manns","year":"2001","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"346","DOI":"10.7326\/0003-4819-140-5-200403020-00010","article-title":"Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose,","volume":"140","author":"SJ Hadziyannis","year":"2004","journal-title":"Ann Intern Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1126\/science.282.5386.103","article-title":"Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy,","volume":"282","author":"AU Neumann","year":"1998","journal-title":"Science"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1053\/gast.2001.24006","article-title":"Viral kinetics in patients with chronic hepatitis C treated with standard or peginterferon alpha2a,","volume":"120","author":"S Zeuzem","year":"2001","journal-title":"Gastroenterology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1089\/107999004322813354","article-title":"Global effect of PEG-IFN-alpha and ribavirin on gene expression in PBMC in vitro,","volume":"24","author":"MW Taylor","year":"2004","journal-title":"J Interferon Cytokine Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"15623","DOI":"10.1073\/pnas.95.26.15623","article-title":"Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays,","volume":"95","author":"SD Der","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1189\/jlb.69.6.912","article-title":"Functional classification of interferon-stimulated genes identified using microarrays,","volume":"69","author":"MJ de Veer","year":"2001","journal-title":"J Leukoc Biol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1089\/jir.2005.25.632","article-title":"Global transcriptional profiling combination of type I and type II demonstrates the interferon enhances antiviral and immune responses at clinically relevant doses,","volume":"25","author":"H Tan","year":"2005","journal-title":"J Interf Cytok Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1128\/JVI.02640-06","article-title":"Changes in gene expression during pegylated interferon and ribavirin therapy of chronic hepatitis C virus distinguish responders from nonresponders to antiviral therapy,","volume":"81","author":"MW Taylor","year":"2007","journal-title":"J Virol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"10101","DOI":"10.1073\/pnas.97.18.10101","article-title":"Singular value decomposition for genome-wide expression data processing and modeling,","volume":"97","author":"O Alter","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref13","article-title":"Algorithms for Clustering Data,","author":"A Jail","year":"1988"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/protein\/14.9.609","article-title":"Similarity of phylogenetic trees as indicator of protein-protein interaction,","volume":"14","author":"F Pazos","year":"2001","journal-title":"Protein engineering"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1093\/bioinformatics\/btg278","article-title":"Inferring protein interactions from phylogenetic distance matrices,","volume":"19","author":"J Gertz","year":"2003","journal-title":"Bioinformatics"},{"key":"ref16","article-title":"Statistical Methods.","author":"GW Snedecor","year":"1989"},{"key":"ref17","article-title":"Multidimensional Scaling.","author":"T Cox","year":"2003"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1089\/jir.2006.26.462","article-title":"Differential Gene Induction by Type I and Type II Interferons and Their Combination,","volume":"26","author":"C Sanda","year":"2006","journal-title":"J Interferon Cytokine Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1053\/jhep.2003.50105","article-title":"Interferon alfa regulated gene expression in patients initiating interferon treatment for chronic hepatitis C,","volume":"37","author":"X Ji","year":"2003","journal-title":"Hepatology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1128\/CMR.14.4.778-809.2001","article-title":"Antiviral actions of interferons,","volume":"14","author":"CE Samuel","year":"2001","journal-title":"Clin Microbiol Rev"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"45194","DOI":"10.1074\/jbc.M400726200","article-title":"Global and distinct targets of IRF-5 and IRF-7 during innate response to viral infection,","volume":"279","author":"BJ Barnes","year":"2004","journal-title":"J Biol Chem"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S1359-6101(97)00019-1","article-title":"The growing family of interferon regulatory factors,","volume":"8","author":"H Nguyen","year":"1997","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/nature03464","article-title":"IRF-7 is the master regulator of type-I interferon-dependent immune responses,","volume":"434","author":"K Honda","year":"2005","journal-title":"Nature"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1084\/jem.20031023","article-title":"LPS-TLR4 signaling to IRF-3\/7 and NF-kappaB involves the toll adapters TRAM and TRIF,","volume":"198","author":"KA Fitzgerald","year":"2003","journal-title":"J Exp Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"5690","DOI":"10.4049\/jimmunol.175.9.5690","article-title":"Regulation of B7.1 costimulatory molecule is mediated by the IFN regulatory factor-7 through the activation of JNK in lipopolysaccharide-stimulated human monocytic cells,","volume":"175","author":"W Lim","year":"2005","journal-title":"J Immunol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"17005","DOI":"10.1074\/jbc.M412584200","article-title":"The interferon regulatory factor, IRF5, is a central mediator of toll-like receptor 7 signaling,","volume":"280","author":"A Schoenemeyer","year":"2005","journal-title":"J Biol Chem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1073\/pnas.0408824102","article-title":"Immune evasion by hepatitis C virus NS3\/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF,","volume":"102","author":"K Li","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1128\/JVI.79.5.2689-2699.2005","article-title":"Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase,","volume":"79","author":"R Sumpter Jr","year":"2005","journal-title":"RIG-I, J Virol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.it.2005.11.004","article-title":"CARD games between virus and host get a new player,","volume":"27","author":"CL Johnson","year":"2006","journal-title":"Trends Immunol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"15669","DOI":"10.1073\/pnas.202608199","article-title":"Genomic analysis of the host response to hepatitis C virus infection,","volume":"99","author":"AI Su","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/hep.20844","article-title":"Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector,","volume":"42","author":"KJ Helbig","year":"2005","journal-title":"Hepatology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"8983","DOI":"10.1128\/JVI.78.17.8983-8993.2004","article-title":"Phospholipid scramblase 1 potentiates the antiviral activity of interferon,","volume":"78","author":"B Dong","year":"2004","journal-title":"J Virol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00262-004-0645-2","article-title":"G1P3, an interferon inducible gene 6\u201316, is expressed in gastric cancers and inhibits mitochondrial-mediated apoptosis in gastric cancer cell line TMK-1 cell,","volume":"54","author":"E Tahara Jr","year":"2005","journal-title":"Cancer Immunol Immunother"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"6770","DOI":"10.1128\/MCB.15.12.6770","article-title":"iPABP, an inducible poly(A)-binding protein detected in activated human T cells,","volume":"15","author":"H Yang","year":"1995","journal-title":"Mol Cell Biol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-2443.2005.00826.x","article-title":"Interaction of anti-proliferative protein Tob with poly(A)-binding protein and inducible poly(A)-binding protein: implication of Tob in translational control,","volume":"10","author":"K Okochi","year":"2005","journal-title":"Genes Cells"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1158\/0008-5472.CAN-05-1123","article-title":"Elevated expression of ISG15 in tumor cells interferes with the ubiquitin\/26S proteasome pathway,","volume":"66","author":"SD Desai","year":"2006","journal-title":"Cancer research"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1182\/blood.V97.1.288","article-title":"Characterization of human sialoadhesin, a sialic acid binding receptor expressed by resident and inflammatory macrophage populations,","volume":"97","author":"A Hartnell","year":"2001","journal-title":"Blood"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.4049\/jimmunol.166.6.3637","article-title":"Cutting edge: CD43 functions as a T cell counterreceptor for the macrophage adhesion receptor sialoadhesin (Siglec-1),","volume":"166","author":"TK van den Berg","year":"2001","journal-title":"J Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1128\/MCB.26.4.1549-1557.2006","article-title":"Sialoadhesin-deficient mice exhibit subtle changes in B- and T-cell populations and reduced immunoglobulin M levels,","volume":"26","author":"C Oetke","year":"2006","journal-title":"Mol Cell Biol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0000584","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T21:02:57Z","timestamp":1683925377000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0000584"}},"subtitle":[],"editor":[{"given":"Sebastian","family":"Fugmann","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2007,7,4]]},"references-count":39,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2007,7,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0000584","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7,4]]}}}